
Current Market Outlook
Last week brought some upside-down action, with the leading growth stocks doing OK (some up, some down) while the lagging names (small- and mid-caps, economically sensitive sectors) did very well. And that trend continued today, with growth stocks getting hit while the major indexes ramped up. Overall, the upmove in the beaten-down areas means the intermediate-term trend has survived its first test, and while taking on some water, growth stocks remain in fine shape, with very little abnormal selling. (In fact, pullbacks in some of the hot names could offer up some solid entry points, but we’ll see how that goes.) All in all, the divergent environment isn’t ideal and will probably lead to further crosscurrents; it remains important to pick your stocks and entry points carefully, and taking some partial profits on the way up isn’t a bad idea, either. But overall, most of the evidence remains positive, so you should, too. Our Market Monitor remains at a level 7.
This week’s list has many names that have just come to life after long rest periods. Our Top Pick is
Spotify (SPOT), which has always had a good story, but now has decisively broken out following a meaningful catalyst.
| Stock Name | Price | Buy Range | Loss Limit |
|---|
| Allogene Therapeutics (ALLO) | 48.94 | 46-48.5 | 40.5-41.5 |
| Big Lots (BIG) | 43.12 | 31-33 | 27-28 |
| BJs Wholesale (BJ) | 36.69 | 34-36.5 | 30.5-32 |
| Guardant Health (GH) | 88.34 | 87.5-91.5 | 79-81 |
| Horizon Therapeutics (HZNP) | 49.89 | 45.5-48 | 40.5-42 |
| Neurocrine Biosciences (NBIX) | 123.40 | 114-119 | 104-107 |
| 1Life Healthcare (ONEM) | 34.01 | 32.5-35 | 28.5-29.5 |
| Spotify (SPOT) | 272.82 | 184-191 | 166-169 |
| Wayfair (W) | 167.03 | 152-162 | 126-130 |
| Wix.com (WIX) | 302.53 | 195-205 | 175-180 |